Canton Hathaway, LLC

Position in MRNA — Moderna, Inc.

CIK 1755785 PROVIDENCE, RI

Position in MRNA

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$42,088

+$11,558 QoQ

Shares Held

601

0.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#563

of 777 holders

Holding Since

Mar 2020

19 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Canton Hathaway, LLC holds $783,315 across 6 Biotechnology names. MRNA ranks #5 (5.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BHVN	Biohaven Ltd.	22,600	$336,288
2	INCY	Incyte Corp	1,500	$170,040
3	PTGX	Protagonist Therapeutics, Inc	1,000	$122,580
4	CHRS	Coherus Oncology, Inc.	58,230	$81,522
5	MRNA	Moderna, Inc. This page	601	$42,088
6	VRTX	Vertex Pharmaceuticals Inc / Ma	62	$30,797

19 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$42,088	601	0.0%	Shares	Sole	2026-08-06
2026-03-31	$30,530	601	0.0%	Shares	Sole	2026-04-24
2024-12-31	$24,989	601	0.0%	Shares	Sole	2025-02-04
2024-09-30	$40,164	601	-57.7%	Shares	Sole	2024-11-13
2024-06-30	$168,743	1,421	+136.4%	Shares	Sole	2024-07-22
2024-03-31	$64,042	601	0.0%	Shares	Sole	2024-05-13
2023-12-31	$59,769	601	-38.1%	Shares	Sole	2024-01-30
2023-09-30	$100,294	971	+61.6%	Shares	Sole	2023-10-11
2023-06-30	$73,021	601	0.0%	Shares	Sole	2023-07-11
2023-03-31	$92,301	601	-54.8%	Shares	Sole	2023-04-11
2022-12-31	$239,074	1,331	+121.5%	Shares	Sole	2023-01-19
2022-09-30	$71,068	601	0.0%	Shares	Sole	2022-10-17
2022-06-30	$85,852	601	0.0%	Shares	Sole	2022-07-20
2022-03-31	$103,528	601	0.0%	Shares	Sole	2022-04-12
2021-12-31	$152,641	601	0.0%	Shares	Sole	2022-01-06
2021-09-30	$231,300	601	-25.0%	Shares	Sole	2021-10-14
2021-06-30	$188,218	801	0.0%	Shares	Sole	2021-07-08
2021-03-31	$104,890	801	-90.4%	Shares	Sole	2021-04-14
2020-03-31	$250,981	8,380	—	Shares	Sole	2020-05-06
No filing history on record for this holder in this stock.